Deals

KKR Will Buy Envision Healthcare for $5.57 Billion Plus Debt

Deal culminates months of review after Starboard took stake
Envision drew interest from UnitedHealth, other PE managers

KKR Secures $5.57 Billion Deal for Envision Healthcare

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Melissa Mittelman

June 11, 2018 at 11:23 AM UTC

Updated on

June 11, 2018 at 10:30 PM UTC

This article is for subscribers only.

Private equity firm KKR & Co. will buy Envision Healthcare Corp. for $5.57 billion plus debt, after a lengthy sale process by the hospital staffing and surgical center company.

Including debt, the all-cash purchase will value Envision at $9.9 billion, the health-care company said in a statement Monday. Envision said the $46-a-share price represents a 32 percent premium to its stock price in November, when it announced it was reviewing strategic alternatives.